# Giuseppe Boriani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giuseppe-boriani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 78,536 |
| Field | Cardiac pacing and defibrillation studies |
| h-index | 108 |
| i10-index | 645 |
| Last Known Institution | University of Modena and Reggio Emilia |
| OpenAlex ID | https://openalex.org/A5114376662 |
| ORCID iD | https://orcid.org/0000-0002-9820-4815 |
| Works | 1,486 |

## Researcher papers

Showing 12 of 13.

- [2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)](https://scholariq.org/papers/2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the-2/)
- [2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy](https://scholariq.org/papers/2013-esc-guidelines-on-cardiac-pacing-and-cardiac-resynchronization-therapy/)
- [The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation](https://scholariq.org/papers/the-2018-european-heart-rhythm-association-practical-guide-on-the-use-of-non/)
- [2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation](https://scholariq.org/papers/2021-european-heart-rhythm-association-practical-guide-on-the-use-of-non-vitamin/)
- [Antithrombotic Therapy for Atrial Fibrillation](https://scholariq.org/papers/antithrombotic-therapy-for-atrial-fibrillation-2/)
- [Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial](https://scholariq.org/papers/ferric-carboxymaltose-for-iron-deficiency-at-discharge-after-acute-heart-failure/)
- [2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)](https://scholariq.org/papers/2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the/)
- [2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias](https://scholariq.org/papers/2025-focused-update-of-the-2019-esc-eas-guidelines-for-the-management-of/)
- [2025 ESC Guidelines for the management of myocarditis and pericarditis](https://scholariq.org/papers/2025-esc-guidelines-for-the-management-of-myocarditis-and-pericarditis/)
- [Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/chronic-kidney-disease-and-arrhythmias-conclusions-from-a-kidney-disease/)
- [The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary](https://scholariq.org/papers/the-2018-european-heart-rhythm-association-practical-guide-on-the-use-of-non-2/)
- [Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry](https://scholariq.org/papers/contemporary-stroke-prevention-strategies-in-11-096-european-patients-with/)

## Researcher topics

- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [University of Modena and Reggio Emilia](https://scholariq.org/institutions/university-of-modena-and-reggio-emilia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.